# OnCo record paper-ifm-2009-attal-nejm-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ifm-2009-attal-nejm-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ifm-2009-attal-nejm-2017" ;
  schema:name "IFM 2009: lenalidomide, bortezomib and dexamethasone with or without upfront transplantation for myeloma"@en ;
  schema:description "Adding an early autologous stem cell transplant to modern three-drug therapy delayed relapse in newly diagnosed myeloma, though overall survival was similar because patients in the drug-only arm could have a transplant later."@en ;
  schema:url <https://onco.cc/key-papers/paper-ifm-2009-attal-nejm-2017/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1611750>, <https://pubmed.ncbi.nlm.nih.gov/28379796/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1611750> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Attal M, Lauwers-Cances V, Hulin C, et al." ;
  onco:cancers <https://onco.cc/cancers/myeloma-transplant-eligible/> ;
  onco:drugs <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:trials <https://onco.cc/trials/ifm-2009/> ;
  onco:journals <https://onco.cc/journals/nejm/> .